Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2439 Neoplasms 1845 Carcinoma, Non-Small-Cell Lung 1615 Prostatic Neoplasms 1315 Colorectal Neoplasms 1149 Lung Neoplasms 993 Neoplasm Metastasis 838 Multiple Myeloma 802 Leukemia, Myeloid, Acute 778 Ovarian Neoplasms 686 Pancreatic Neoplasms 673 Melanoma 669 Squamous Cell Carcinoma of Head and Neck 592 Carcinoma, Hepatocellular 571 Recurrence 570 Brain Neoplasms 531 Glioblastoma 521 Stomach Neoplasms 506 Head and Neck Neoplasms 504 Triple Negative Breast Neoplasms 474 Lymphoma 463 Uterine Cervical Neoplasms 457 Carcinoma, Renal Cell 430 Precursor Cell Lymphoblastic Leukemia-Lymphoma 421 Lymphoma, Non-Hodgkin 392 Endometrial Neoplasms 386 Sarcoma 372 Lymphoma, Follicular 358 Urinary Bladder Neoplasms 356 Lymphoma, Large B-Cell, Diffuse 356

Interventions

Elasticity Imaging Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreas Adenocarcinomas × 1 year × Clear all

NCT06842303 2025-07-17

PADME

Central Hospital, Nancy, France

Phase NA Recruiting

Gastrointestinal

Pancreas Adenocarcinomas

Data powered by HemOnc (CC BY 4.0) Colophon ⚡